GlycoVaxyn's Series A Round

GlycoVaxyn raised a round of funding on July 17, 2007.

GlycoVaxyn is a clinical stage biopharmaceutical company focused on the development and manufacture of next-generation bioconjugate vaccines utilizing its proprietary recombinant DNA technology. Glyco…

Articles about GlycoVaxyn's Series A Round: